News

Technology News

NeuroMetrix Launches 2nd Gen SENSUS Device

Wednesday, March 19, 2014 5:15:00 AM PDT | VentureDeal
   Waltham, Massachusetts  --  NeuroMetrix (NASDAQ: NURO) has announced the launch of the 2nd generation of its pain management system.

Called SENSUS, the technology utilizes electrical nerve stimulation to induce elevation of neural modulatory chemicals enkephalins, which block the transmission of pain signals.

The device is a transcutaneous electrical nerve stimulator with indications for a variety of chronic pain symptoms.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1